• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘精胰岛素和德谷胰岛素:高剂量合成胰岛素的溶液行为。

Glargine and degludec: Solution behaviour of higher dose synthetic insulins.

机构信息

The University of Nottingham, Faculty of Medicine and Health Sciences, Queen's Medical Centre, Nottingham, NG7 2UH, UK.

The University of Nottingham, School of Biosciences, National Centre for Macromolecular Hydrodynamics (NCMH), Sutton Bonington Campus, Sutton Bonington, Leicestershire, LE12 5RD, UK.

出版信息

Sci Rep. 2017 Aug 4;7(1):7287. doi: 10.1038/s41598-017-06642-w.

DOI:10.1038/s41598-017-06642-w
PMID:28779138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5544765/
Abstract

Single, double and triple doses of the synthetic insulins glargine and degludec currently used in patient therapy are characterised using macromolecular hydrodynamic techniques (dynamic light scattering and analytical ultracentrifugation) in an attempt to provide the basis for improved personalised insulin profiling in patients with diabetes. Using dynamic light scattering and sedimentation velocity in the analytical ultracentrifuge glargine was shown to be primarily dimeric under solvent conditions used in current formulations whereas degludec behaved as a dihexamer with evidence of further association of the hexamers ("multi-hexamerisation"). Further analysis by sedimentation equilibrium showed that degludec exhibited reversible interaction between mono- and-di-hexamer forms. Unlike glargine, degludec showed strong thermodynamic non-ideality, but this was suppressed by the addition of salt. With such large injectable doses of synthetic insulins remaining in the physiological system for extended periods of time, in some case 24-40 hours, double and triple dose insulins may impact adversely on personalised insulin profiling in patients with diabetes.

摘要

目前用于患者治疗的甘精胰岛素和德谷胰岛素的单、双、三倍剂量,使用高分子流体力学技术(动态光散射和分析超速离心)进行了表征,以期为糖尿病患者的个体化胰岛素分析提供基础。使用分析超速离心的动态光散射,在当前配方中使用的溶剂条件下,甘精胰岛素主要表现为二聚体,而德谷胰岛素表现为二六聚体,并且存在六聚体的进一步缔合(“多六聚体化”)。进一步的沉降平衡分析表明,德谷胰岛素表现出单六聚体形式和双六聚体形式之间的可逆相互作用。与甘精胰岛素不同,德谷胰岛素表现出强烈的热力学非理想性,但添加盐可以抑制这种非理想性。由于这些大剂量的合成胰岛素在生理系统中长时间(某些情况下为 24-40 小时)保持存在,双剂量和三剂量胰岛素可能会对糖尿病患者的个体化胰岛素分析产生不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/a0d9062c81e9/41598_2017_6642_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/0c0ed6bd4d8e/41598_2017_6642_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/86fd4d01f7d2/41598_2017_6642_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/dfcad25cc204/41598_2017_6642_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/cdb3e79d91de/41598_2017_6642_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/a0d9062c81e9/41598_2017_6642_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/0c0ed6bd4d8e/41598_2017_6642_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/86fd4d01f7d2/41598_2017_6642_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/dfcad25cc204/41598_2017_6642_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/cdb3e79d91de/41598_2017_6642_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535f/5544765/a0d9062c81e9/41598_2017_6642_Fig5_HTML.jpg

相似文献

1
Glargine and degludec: Solution behaviour of higher dose synthetic insulins.甘精胰岛素和德谷胰岛素:高剂量合成胰岛素的溶液行为。
Sci Rep. 2017 Aug 4;7(1):7287. doi: 10.1038/s41598-017-06642-w.
2
Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) - a review of evidence and clinical interpretation.胰岛素地特胰岛素(100、200 U/mL)和甘精胰岛素(100、300 U/mL)的药代动力学和药效学特征的临床相关性-证据回顾与临床解读。
Diabetes Metab. 2019 Sep;45(4):330-340. doi: 10.1016/j.diabet.2018.11.004. Epub 2018 Nov 26.
3
Morning administration of 0.4U/kg/day insulin glargine 300U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared with insulin degludec 100U/mL in type 1 diabetes.与 100U/mL 德谷胰岛素相比,1 型糖尿病患者每天接受 0.4U/kg 甘精胰岛素 300U/mL 治疗,其 24 小时药效动力学波动更小,药代动力学更平稳。
Diabetes Metab. 2018 Feb;44(1):15-21. doi: 10.1016/j.diabet.2017.10.001. Epub 2017 Nov 16.
4
Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine.德谷胰岛素与甘精胰岛素的药代动力学和药效学特征比较。
Expert Opin Drug Metab Toxicol. 2015;11(8):1193-201. doi: 10.1517/17425255.2015.1058779. Epub 2015 Jun 18.
5
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.从每日两次甘精胰岛素或地特胰岛素转换为每日一次德谷胰岛素可改善1型糖尿病患者的血糖控制。一项观察性研究。
Nutr Metab Cardiovasc Dis. 2016 Dec;26(12):1112-1119. doi: 10.1016/j.numecd.2016.08.002. Epub 2016 Aug 6.
6
Concentrated insulin glargine (Toujeo) for diabetes.用于糖尿病治疗的甘精胰岛素浓缩液(托优益)
Med Lett Drugs Ther. 2015 May 11;57(1468):69-70.
7
Insulin degludec requires lower bolus insulin doses than does insulin glargine in Japanese diabetic patients with insulin-dependent state.在日本胰岛素依赖型糖尿病患者中,德谷胰岛素所需的大剂量胰岛素比甘精胰岛素少。
J Diabetes Sci Technol. 2015 May;9(3):632-8. doi: 10.1177/1932296814564396. Epub 2014 Dec 18.
8
Adjustment of insulin doses when switching from glargine 100 U/ml or detemir to degludec: an observational study.从甘精胰岛素 100U/ml 或地特胰岛素转换为德谷胰岛素时的胰岛素剂量调整:一项观察性研究。
J Endocrinol Invest. 2019 Mar;42(3):319-326. doi: 10.1007/s40618-018-0920-2. Epub 2018 Jul 9.
9
Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart.使长效胰岛素德谷与速效胰岛素门冬共配制的物理化学性质研究。
Pharm Res. 2015 Jul;32(7):2250-8. doi: 10.1007/s11095-014-1614-x. Epub 2015 Jan 8.
10
Comparative clinical outcomes of insulin degludec and insulin glargine 300 U/mL after switching from other basal insulins in real-world patients with type 1 and type 2 diabetes.在真实世界中,1 型和 2 型糖尿病患者从其他基础胰岛素转换为德谷胰岛素和甘精胰岛素 300U/mL 后的临床结局比较。
J Diabetes Investig. 2021 Nov;12(11):1983-1991. doi: 10.1111/jdi.13559. Epub 2021 May 3.

引用本文的文献

1
Pharmacological and Benefit-Risk Profile of Once-Weekly Basal Insulin Administration (Icodec): Addressing Patients' Unmet Needs and Exploring Future Applications.每周一次基础胰岛素给药(icodec)的药理学及获益-风险概况:满足患者未被满足的需求并探索未来应用
J Clin Med. 2024 Apr 5;13(7):2113. doi: 10.3390/jcm13072113.
2
Analysis of insulin glulisine at the molecular level by X-ray crystallography and biophysical techniques.通过 X 射线晶体学和生物物理技术对胰岛素谷赖氨酸进行分子水平分析。
Sci Rep. 2021 Jan 18;11(1):1737. doi: 10.1038/s41598-021-81251-2.
3
Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary.

本文引用的文献

1
Rational steering of insulin binding specificity by intra-chain chemical crosslinking.通过链内化学交联对胰岛素结合特异性进行合理调控。
Sci Rep. 2016 Jan 21;6:19431. doi: 10.1038/srep19431.
2
Disulfide Linkage Characterization of Disulfide Bond-Containing Proteins and Peptides by Reducing Electrochemistry and Mass Spectrometry.利用还原电化学和质谱法对含二硫键的蛋白质和肽的二硫键进行结构分析。
Anal Chem. 2016 Feb 2;88(3):1585-92. doi: 10.1021/acs.analchem.5b03148. Epub 2016 Jan 8.
3
The osmotic second virial coefficient for protein self-interaction: Use and misuse to describe thermodynamic nonideality.
2型糖尿病患者基础胰岛素的有效起始与治疗:关注降低高危患者低血糖风险:执行摘要
Clin Diabetes. 2020 Oct;38(4):324-327. doi: 10.2337/cd20-0035.
4
Clinically Relevant Insulin Degludec and its Interaction with Polysaccharides: A Biophysical Examination.临床相关的德谷胰岛素及其与多糖的相互作用:一项生物物理研究。
Polymers (Basel). 2020 Feb 9;12(2):390. doi: 10.3390/polym12020390.
5
Characterisation of insulin analogues therapeutically available to patients.胰岛素类似物的治疗特性分析。
PLoS One. 2018 Mar 29;13(3):e0195010. doi: 10.1371/journal.pone.0195010. eCollection 2018.
蛋白质自相互作用的渗透第二维里系数:用于描述热力学非理想性的正确与错误用法。
Anal Biochem. 2015 Dec 1;490:55-65. doi: 10.1016/j.ab.2015.08.020. Epub 2015 Sep 3.
4
Insulin analogues display atypical differentiative activities in skin keratinocytes.胰岛素类似物在皮肤角质形成细胞中表现出非典型的分化活性。
Arch Physiol Biochem. 2015 Feb;121(1):32-9. doi: 10.3109/13813455.2014.1001856. Epub 2015 Apr 21.
5
Proliferative and signaling activities of insulin analogues in endometrial cancer cells.胰岛素类似物在子宫内膜癌细胞中的增殖和信号传导活性。
Mol Cell Endocrinol. 2015 May 5;406:27-39. doi: 10.1016/j.mce.2015.02.011. Epub 2015 Feb 16.
6
Concentration dependence of translational diffusion coefficients for globular proteins.球状蛋白质平移扩散系数的浓度依赖性。
Analyst. 2014 Dec 7;139(23):6242-8. doi: 10.1039/c4an01060d.
7
Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycaemic control in T1DM and T2DM.与新型长效胰岛素 LY2605541 和甘精胰岛素相比,尽管在 1 型和 2 型糖尿病中都能改善血糖控制,但体重变化却截然不同。
Diabetes Obes Metab. 2014 Apr;16(4):351-6. doi: 10.1111/dom.12223.
8
Basal insulin analogues in the management of diabetes mellitus: What progress have we made?基础胰岛素类似物在糖尿病治疗中的应用:我们取得了哪些进展?
Diabetes Metab Res Rev. 2014 Feb;30(2):104-19. doi: 10.1002/dmrr.2469.
9
MultiSig: a new high-precision approach to the analysis of complex biomolecular systems.多重签名:一种分析复杂生物分子系统的全新高精度方法。
Eur Biophys J. 2013 Oct;42(10):777-86. doi: 10.1007/s00249-013-0924-y. Epub 2013 Aug 29.
10
Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.糖尿病患者的低血糖无感知和低血糖反应缺陷:机制和新兴治疗方法。
Endocrinol Metab Clin North Am. 2013 Mar;42(1):15-38. doi: 10.1016/j.ecl.2012.11.005. Epub 2012 Dec 12.